1. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (
http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
). In: HIV/AIDS, editor. Geneva ISBN: 978 92 4,150,956 52,015. Accessed 22 April 2019.
2. UNAIDS. UNAIDS Data Book Geneva: UNAIDS; 2018 [Available from:
http://www.unaids.org/en/resources/documents/2018/unaids-data-2018
. Accessed 22 April 2019.
3. Nash D, Yotebieng M, Sohn AH. Treating all people with HIV infection in sub-Saharan Africa: a new era calling for new approaches. J Viral Erad. 2018;4(Suppl 2):1–4.
4. Lange JM. Editorial commentary: Under the spell of the red queen. Clin Infect Dis. 2013;57(7):1048–50.
5. •• IeDEA, Collaboration. Global trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of treatment programs. Clin Infect Dis. 2018;66(6):893–903. This study generated global estimates of the trend in CD4 counts at ART initiation.